OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cyanometabolites: molecules with immense antiviral potential
Uma Singh, Harsh A. Gandhi, Nikita Nikita, et al.
Archives of Microbiology (2023) Vol. 205, Iss. 5
Open Access | Times Cited: 14
Uma Singh, Harsh A. Gandhi, Nikita Nikita, et al.
Archives of Microbiology (2023) Vol. 205, Iss. 5
Open Access | Times Cited: 14
Showing 14 citing articles:
Marine natural products
Anthony R. Carroll, Brent R. Copp, Tanja Grkovic, et al.
Natural Product Reports (2025)
Open Access | Times Cited: 2
Anthony R. Carroll, Brent R. Copp, Tanja Grkovic, et al.
Natural Product Reports (2025)
Open Access | Times Cited: 2
A comprehensive review of the therapeutic potential of cyanobacterial marine bioactives: Unveiling the hidden treasures of the sea
Taufiq Nawaz, Liping Gu, Shah Fahad, et al.
Food and Energy Security (2023) Vol. 12, Iss. 5
Open Access | Times Cited: 29
Taufiq Nawaz, Liping Gu, Shah Fahad, et al.
Food and Energy Security (2023) Vol. 12, Iss. 5
Open Access | Times Cited: 29
Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial
Mohammad Reza Aghasadeghi, Mohammad Ali Zaheri Birgani, Saeedreza Jamalimoghadamsiyahkali, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Mohammad Reza Aghasadeghi, Mohammad Ali Zaheri Birgani, Saeedreza Jamalimoghadamsiyahkali, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Isolation and structure elucidation of Dm-CVNH, a new cyanovirin-N homolog with activity against SARS-CoV-2 and HIV-1
Maria Orfanoudaki, Lauren R. H. Krumpe, Shilpa R. Shenoy, et al.
Journal of Biological Chemistry (2025), pp. 108319-108319
Open Access
Maria Orfanoudaki, Lauren R. H. Krumpe, Shilpa R. Shenoy, et al.
Journal of Biological Chemistry (2025), pp. 108319-108319
Open Access
Cyanotoxins: Industrial Potential
Dhammika Magana-Arachchi, H. M. S. A. T. Gunathilaka
(2025), pp. 89-120
Closed Access
Dhammika Magana-Arachchi, H. M. S. A. T. Gunathilaka
(2025), pp. 89-120
Closed Access
A review of the use of cyanobacterial metabolites in the treatment of viral and cancer diseases
Bahareh Nowruzi, Fatemeh Bagheri
Deleted Journal (2025) Vol. 35, Iss. 1, pp. 1-13
Closed Access
Bahareh Nowruzi, Fatemeh Bagheri
Deleted Journal (2025) Vol. 35, Iss. 1, pp. 1-13
Closed Access
Antimicrobial peptides for novel antiviral strategies in the current post‐COVID‐19 pandemic
Maria Rosa Loffredo, Lucia Nencioni, Maria Luisa Mangoni, et al.
Journal of Peptide Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 10
Maria Rosa Loffredo, Lucia Nencioni, Maria Luisa Mangoni, et al.
Journal of Peptide Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 10
Microbial lectins as a potential therapeutics for the prevention of certain human diseases
Suna Bektas, Engin Kaptan
Life Sciences (2024) Vol. 346, pp. 122643-122643
Closed Access | Times Cited: 3
Suna Bektas, Engin Kaptan
Life Sciences (2024) Vol. 346, pp. 122643-122643
Closed Access | Times Cited: 3
Mechanistic Insights into Targeting SARS-CoV-2 Papain-like Protease in the Evolution and Management of COVID-19
Nonjabulo Ntombikhona Magwaza, Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, et al.
BioChem (2024) Vol. 4, Iss. 3, pp. 268-299
Open Access | Times Cited: 2
Nonjabulo Ntombikhona Magwaza, Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, et al.
BioChem (2024) Vol. 4, Iss. 3, pp. 268-299
Open Access | Times Cited: 2
Cyanobacteria and their metabolites - can they be helpful in the fight against pathogenic microbes?
Łukasz Grabowski, Karolina Wiśniewska, Magdalena Żabińska, et al.
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access | Times Cited: 1
Łukasz Grabowski, Karolina Wiśniewska, Magdalena Żabińska, et al.
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access | Times Cited: 1
Marine Cyanobacteria: A Rich Source of Structurally Unique Anti-Infectives for Drug Development
Lik Tong Tan, Nurul Farhana Salleh
Molecules (2024) Vol. 29, Iss. 22, pp. 5307-5307
Open Access | Times Cited: 1
Lik Tong Tan, Nurul Farhana Salleh
Molecules (2024) Vol. 29, Iss. 22, pp. 5307-5307
Open Access | Times Cited: 1
Algae Polysaccharides (Carrageenan and Alginate)—A Treasure-Trove of Antiviral Compounds: An In Silico Approach to Identify Potential Candidates for Inhibition of S1-RBD Spike Protein of SARS-CoV2
Dikshansha Rohilla, Akhileshwar Kumar Srivastava, Rahul Singh, et al.
Stresses (2023) Vol. 3, Iss. 3, pp. 555-569
Open Access | Times Cited: 3
Dikshansha Rohilla, Akhileshwar Kumar Srivastava, Rahul Singh, et al.
Stresses (2023) Vol. 3, Iss. 3, pp. 555-569
Open Access | Times Cited: 3
Metabolic Materials from Cyanobacteria and Microalgae: Biotechnology, Biochemistry and Biotherapeutics
Lokitha Paduvetnaya, Kamath H. Venkatesh, Harishkumar Madhyastha
Energy, environment, and sustainability (2024), pp. 489-518
Closed Access
Lokitha Paduvetnaya, Kamath H. Venkatesh, Harishkumar Madhyastha
Energy, environment, and sustainability (2024), pp. 489-518
Closed Access
Pharmacological potential of cyanobacteria secondary metabolites
Caroline da Costa Silva Gonçalves, Maria Gabriela Azevedo Barros, Juliana Kafka Bilha, et al.
Studies in natural products chemistry (2024), pp. 385-409
Closed Access
Caroline da Costa Silva Gonçalves, Maria Gabriela Azevedo Barros, Juliana Kafka Bilha, et al.
Studies in natural products chemistry (2024), pp. 385-409
Closed Access
